share_log

Prelude Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-UBS Group AG (for the benefit and on behalf of the UBS Asset(0%)

SEC ·  Feb 14 02:35
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.